152 related articles for article (PubMed ID: 18806462)
21. [The role of molecular biology in the diagnosis and treatment of cardiovascular diseases].
Mariotti S; Capparuccia C; Ripa C; Olivieri F; Lisa R; Procopio A; Antonicelli R
G Ital Cardiol (Rome); 2010 Oct; 11(10):730-45. PubMed ID: 21246774
[TBL] [Abstract][Full Text] [Related]
22. [The genetics of multifactorial cardiovascular disease. How significant for the cardiologist?].
Bauters C; Lamblin N; Amouyel P
Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1127-30. PubMed ID: 14694791
[TBL] [Abstract][Full Text] [Related]
23. Genetic and molecular markers for vascular disease. Overview.
Ballantyne CM
J Cardiovasc Risk; 1997; 4(5-6):321-3. PubMed ID: 9865661
[No Abstract] [Full Text] [Related]
24. Genomics of cardiovascular disease.
O'Donnell CJ; Nabel EG
N Engl J Med; 2011 Dec; 365(22):2098-109. PubMed ID: 22129254
[No Abstract] [Full Text] [Related]
25. [Genetic factors and the risk of cardiovascular diseases].
Teren A; Gavorník P
Vnitr Lek; 2007 Jun; 53(6):678-93. PubMed ID: 17702128
[TBL] [Abstract][Full Text] [Related]
26. Commentary: Katan's remarkable foresight: genes and causality 18 years on.
Keavney B
Int J Epidemiol; 2004 Feb; 33(1):11-4. PubMed ID: 15075138
[No Abstract] [Full Text] [Related]
27. The year in atherothrombosis.
Sanz J; Moreno PR; Fuster V
J Am Coll Cardiol; 2007 Apr; 49(16):1740-9. PubMed ID: 17448377
[No Abstract] [Full Text] [Related]
28. Family history of heart disease: the re-emergence of a traditional risk factor.
Assimes TL
J Am Coll Cardiol; 2011 Feb; 57(5):628-9. PubMed ID: 21272755
[No Abstract] [Full Text] [Related]
29. Ethical issues in screening and testing for genetic diseases.
Kadlec JV; McPherson RA
Clin Lab Med; 1995 Dec; 15(4):989-99. PubMed ID: 8838235
[TBL] [Abstract][Full Text] [Related]
30. The environment, epigenetic landscape and cardiovascular risk.
Suades R; Cosentino F
Cardiovasc Res; 2019 Nov; 115(13):e147-e150. PubMed ID: 31230064
[No Abstract] [Full Text] [Related]
31. Shared genetic factors in the co-occurrence of symptoms of depression and cardiovascular risk factors.
López-León S; Aulchenko YS; Tiemeier H; Oostra BA; van Duijn CM; Janssens AC
J Affect Disord; 2010 May; 122(3):247-52. PubMed ID: 19674795
[TBL] [Abstract][Full Text] [Related]
32. Understanding cardiovascular disease through the lens of genome-wide association studies.
Arking DE; Chakravarti A
Trends Genet; 2009 Sep; 25(9):387-94. PubMed ID: 19716196
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities.
Khamaisi M; Wexler ID; Skrha J; Strojek K; Raz I; Milicevic Z
Isr Med Assoc J; 2003 Nov; 5(11):801-6. PubMed ID: 14650106
[TBL] [Abstract][Full Text] [Related]
34. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
Jansen AC; van Aalst-Cohen ES; Tanck MW; Cheng S; Fontecha MR; Li J; Defesche JC; Kastelein JJ
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
[TBL] [Abstract][Full Text] [Related]
35. Genetic association studies in cardiovascular diseases: Do we have enough power?
Auer PL; Stitziel NO
Trends Cardiovasc Med; 2017 Aug; 27(6):397-404. PubMed ID: 28456354
[TBL] [Abstract][Full Text] [Related]
36. Network-based drugs: promise and clinical challenges in cardiovascular disease.
Roukos DH; Katsouras CS; Baltogiannis GG; Naka KK; Michalis LK
Expert Rev Proteomics; 2013 Apr; 10(2):119-22. PubMed ID: 23573777
[No Abstract] [Full Text] [Related]
37. [Analyses of genetic risk factors associated to chronic nephropathy of renal transplant: genetic polymorphisms of cytokynes, adhesion molecules, platelet-coagulation system and cardiovascular risk markers].
Cobo M; Barrios Y; Iñigo P; Bigo C; Alvarez A; Martín B; Campistol JM; Hernández D; Salido E; Torres A
Nefrologia; 2004; 24 Suppl 4():49-56. PubMed ID: 15279387
[No Abstract] [Full Text] [Related]
38. [News in cardiovascular genetics open for new therapeutic possibilities].
Nilsson PM; Orho-Melander M; Melander O
Lakartidningen; 2011 Mar 9-15; 108(10):540-3. PubMed ID: 21744555
[No Abstract] [Full Text] [Related]
39. The contribution of six polymorphisms to cardiovascular risk in a Dutch high-risk primary care population: the HIPPOCRATES project.
Plat AW; Stoffers HE; Klungel OH; van Schayck CP; de Leeuw PW; Soomers FL; Schiffers PM; Kester AD; Kroon AA
J Hum Hypertens; 2009 Oct; 23(10):659-67. PubMed ID: 19242491
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk factors in obese women and their first-degree relatives.
Saraç F; Ozgen AG; Yilmaz C; Tüzün M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
